A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan

To improve efficacy and minimize toxicity of EGFR inhibition treatment, we developed Ame55, a novel anti-EGFR IgG1 with lower affinity to EGFR than cetuximab (C225) from a human phage library. Ame55 had lower bioactivity than cetuximab in vitro but similar antitumor efficacy as cetuximab in vivo. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Weiyi, Zhang, Chang, Wang, Shuang, Yu, Xiaoyan, Wang, Qiong, Zeng, Dadi, Du, Peng, Ma, Jinling, Zheng, Yiqiong, Pang, Bo, Yu, Yunzhou, Long, Feng, Pang, Xiaobin, Sun, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348820/
https://www.ncbi.nlm.nih.gov/pubmed/30733972
http://dx.doi.org/10.1155/2019/3017360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348820/
https://www.ncbi.nlm.nih.gov/pubmed/30733972
http://dx.doi.org/10.1155/2019/3017360

Ejemplares similares